A possible explanation could be attributed to the higher doses of vitamin D recommended in patients with high PTH levels in an attempt to contain secondary hyperparathyroidism [46], with vitamin D also having an important role in the regulation of the immune system, modulating both the inflammatory response [47] and musculoskeletal adaptations in HD patients [48]. Here, PTH is linked to secondary hyperparathyroidism.